The H126 yellow pill is a prescription medication containing Pantoprazole Sodium Delayed-Release 40 mg. Distributed by Quallent Pharmaceuticals (and manufactured by Hetero Labs), it is a generic form of the brand-name proton pump inhibitor (PPI) Protonix.
Physical Identification
Characteristic Details
- Active Ingredient Pantoprazole Sodium (40 mg)
- Imprint “H126” on one side, plain on the reverse
- Color Yellow
- Shape Oval
- Coating Delayed-release (enteric-coated to protect the drug from stomach acid)
- Distributor/Manufacturer Quallent Pharmaceuticals / Hetero Labs
- (Note: A round brown pill imprinted with “H 126” corresponds to Ropinirole Hydrochloride 4 mg, an antiparkinsonian medication. Always verify both color, imprint, and shape with a pharmacist.)
Mechanism of Action
Pantoprazole is a proton pump inhibitor (PPI) that reduces the production of gastric acid.
- Gastric Parietal Cell Activation: Pantoprazole accumulates in the acidic environment of the stomach’s parietal cell canaliculi, where it is converted into its active sulfenamide form.
- Inhibition of ATPase: The active form covalently binds to the cysteine residues of the ATPase enzyme system (the “proton pump”) on the secretory surface of parietal cells.
- Acid Suppression: By blocking this final step in acid secretion, pantoprazole inhibits both basal and stimulated gastric acid production, allowing damaged esophageal and stomach tissues to heal.
Indications & Dosage
Pantoprazole 40 mg is indicated for short-term and long-term acid suppression.
Adult Dosing Guidelines
- Erosive Esophagitis associated with GERD: 40 mg once daily for up to 8 weeks. An additional 8-week course may be considered if healing is incomplete.
- Maintenance of Healing of Erosive Esophagitis: 40 mg once daily.
- Pathological Hypersecretory Conditions (e.g., Zollinger-Ellison Syndrome): Starting dose is usually 40 mg twice daily, adjusted up to 240 mg per day in severe cases.
Administration Rules
- Swallow tablets whole with or without food.
- Do not crush, split, or chew the delayed-release tablet, as breaking the enteric coating degrades the active drug in stomach acid before it can be absorbed in the intestines.
Side Effects
Common Side Effects
Most side effects are mild and short-lived:
- Headache
- Diarrhea or constipation
- Nausea and abdominal pain
- Flatulence (gas)
- Dizziness or joint pain
Serious Side Effects (Long-Term or Severe Use)
Seek immediate medical attention if you experience:
- Clostridioides difficile (C. diff) Diarrhea: Severe, watery, or persistent diarrhea with fever.
- Bone Fractures: Long-term, high-dose use increases the risk of osteoporosis-related fractures of the hip, wrist, or spine.
- Cutaneous or Systemic Lupus Erythematosus: New or worsening joint pain and a skin rash on cheeks or arms that worsens in sunlight.
- Severe Allergic Reactions (Anaphylaxis): Rash, swelling of the face, tongue, or throat, or trouble breathing.
- Low Magnesium (Hypomagnesemia): Seizures, irregular heartbeat, muscle spasms, or tremors (typically after 3+ months of continuous use).
Precautions & Warnings
- Gastric Malignancy Risk: Symptomatic response to pantoprazole therapy does not preclude the presence of underlying gastric malignancy.
- Vitamin B12 Deficiency: Daily treatment over a long period (more than 3 years) can lead to malabsorption of vitamin due to cyanocobalamin hypochlorhydria.
- Acute Tubulointerstitial Nephritis (TIN): May occur at any point during PPI therapy and can progress to renal failure.
- Interaction with HIV Medications: Co-administration with rilpivirine-containing regimens is strictly contraindicated due to significant loss of antiviral efficacy.
Major Drug Interactions
Medication / Class Interaction Effect Clinical Management
- Rilpivirine, Atazanavir, Nelfinavir Reduces antiretroviral absorption due to increased gastric pH. Contraindicated. Avoid concurrent use.
- Warfarin May increase INR and prothrombin time, increasing bleeding risk. | Monitor INR and prothrombin time closely.
- Methotrexate High-dose methotrexate with PPIs may increase blood levels of methotrexate. Consider temporarily stopping PPI during high-dose methotrexate therapy.
- Iron Supplements, Ketoconazole Reduced gastric acid impairs oral absorption of these drugs. Adjust timing or dosage as recommended by a physician.